Sequence Design, Proof of Concept, Process Development, mRNA Production, LNP Encapsulation, Quality Control, Quality Control Method Development Validation, PRRSV, PRRSV mRNA Vaccine, mRNA Vaccine, Cat Tetravalent, Cat Tetravalent mRNA Vaccine, Animal Spaying Animal Neutering, Animal Spaying mRNA Vaccine, Animal Neutering mRNA Vaccine, mRNA Synthesis.

HZYMES has launched a range of services and products suited for early-stage research and scientific customers, simplifying the preparation process of research-grade mRNA/LNP. This approach meets the needs of early research clients who prioritize speed and cost, significantly reducing equipment and time costs during the preliminary research stage. This enables "zero-barrier" entry into the mRNA platform, contributing to the continuous development of the industry.

We are pleased to invite you to visit us at the New York Vet Show 2024, where we will be presenting our pioneering HZYMES Animal mRNA Vaccine line. Join us to explore cutting-edge innovations that are advancing animal health and veterinary care with highly effective mRNA vaccines.

As a leader in vaccine innovation, HZYMES BIOTECH is proud to be part of this prestigious event. We invite you to visit us at Booth No. 01, where we will showcase our cutting-edge solutions for mRNA drug development.